Biography
Caryn Plummer's research interests include corneal wound healing, immune-mediated uveitis and glaucoma. She deals with the diagnosis, treatment and understanding of diseases of the eye in veterinary species. She has lectured extensively both in the USA and abroad on many topics associated with clinical veterinary ophthalmology and animal models of ophthalmic disease, especially glaucoma.
Areas of Expertise (10)
Canine Glaucoma
Comparative Ophthalmology
Corneal Wound Healing
Equine Ophthalmology
Equine Recurrent Uveitis
Immune-mediated Uveitis
Infectious Keratitis
Keratomycosis
Ocular Pharmacology
Veterinary Ophthalmology
Media Appearances (3)
Can cats really see in the dark?
Live Science online
2022-09-15
If you've ever lived with a cat, you know that they can be incredibly active at night, often sprinting up and down corridors — and over their owners' beds — without ever crashing into walls or doors.
University of Florida veterinarians provide heart and eye check ups to service dogs
The Gainesville Sun online
2022-05-20
Beau, a labradoodle, wags his tail with excitement as Dr. Caryn Plummer, a professor and board-certified veterinary ophthalmologist at the UF College of Veterinary Medicine, approaches with a hand-held device to check his eyes.
UF Small Animal Hospital to offer free eye, heart screenings for service animals
UF Health online
2022-03-16
The University of Florida’s Small Animal Hospital will offer free eye and heart screenings for service animals on May 20 as part of the American College of Veterinary Ophthalmologists-StokesRx National Service Animal Eye Exam event.
Articles (3)
Comparison of ophthalmic loteprednol etabonate and prednisolone acetate effects on adrenocortical response to ACTH in dogs
Veterinary OphthalmologyKyle E. Kline, et. al
2022-08-01
This study served to compare the degree of adrenocortical suppression following a 2-week administration of loteprednol etabonate (LE) and prednisolone acetate (PA) ophthalmic drops. In this prospective double-masked triple-crossover study, 21 clinically healthy dogs were randomized to receive loteprednol etabonate ophthalmic suspension 0.5%, prednisolone acetate ophthalmic suspension 1%, or artificial tears (AT).
Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide
Scientific ReportsCaryn E. Plummer, et. al
2022-05-03
Equine recurrent uveitis (ERU) is a painful and debilitating autoimmune disease and represents the only spontaneous model of human recurrent uveitis (RU). Despite the efficacy of existing treatments, RU remains a leading cause of visual handicap in horses and humans. Cytokines, which utilize Janus kinase 2 (Jak2) for signaling, drive the inflammatory processes in ERU that promote blindness.
Therapeutic effects of equine amniotic membrane suspension on corneal re-epithelialization and haze in a modified lagomorph ex vivo wound healing model
Veterinary OphthalmologyChristine K. Boss, et. al
2021-11-17
To investigate the therapeutic effects of topical equine amniotic membrane (eAM) suspension following corneal wounding in a controlled experimental setting. Equine amniotic membrane was collected, gamma irradiated, homogenized for topical suspension preparation and cryopreserved. Corneoscleral rims harvested from fresh rabbit globes were wounded via keratectomy and were maintained in an air-liquid interface ex vivo corneal culture model.